Save

You have reached your maximum number of saved items.

Remove items from your saved list to add more.

A A A

A whistleblower tried twice to warn Australia’s medical regulator about false claims made by a defibrillator maker, but officials took no action.

It can also be revealed that the CellAED defibrillator had been tested only on two pigs when its Australian manufacturer, Rapid Response Revival, applied for approval. Yet far from restarting their hearts, the device electrocuted both animals.

The developments heap fresh pressure on the Therapeutic Goods Administration (TGA), after this masthead’s Medical Malfunctions investigation revealed weak…

Read the full article at SMH.COM.AU